January 31, 2020
Vienna, Austria, Holzgerlingen, Germany, and Shenzhen, China, January 30, 2020, 08:00 am CET – Ares Genetics GmbH, a Curetis Group company, and the Chinese genomics company […]
January 22, 2020
With superbugs causing upwards of 35,000 deaths per year, the global antibiotic crisis is intensifying, says the World Health Organization (WHO)—and depending which direction policymakers go, antimicrobial resistance […]
January 16, 2020
Science 10 Jan 2020: Vol. 367, Issue 6474, pp. 143-144, Mette Kalager & Michael Bretthauer National cancer screening programs, such as mammography for breast cancer, are widely […]
January 14, 2020
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, January 14, 2020, 08:00 am CET — Curetis N.V. (the “Company” and, together with its subsidiaries, […]
December 23, 2019
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, December 20, 2019, 23:30 CET — Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), […]
December 10, 2019
Vienna, Austria, and Holzgerlingen, Germany, December 10, 2019, 08:00 am CET – Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of next-level […]
December 3, 2019
BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) — Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), today reported on micro-simulation model results indicating that Epi proColon®, a […]
November 25, 2019
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, November 25, 2019, 08:00 am CET — Curetis N.V. (the “Company” and, together with its subsidiaries, […]
November 7, 2019
Vela Diagnostics’ Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo designated Next Generation Sequencing (NGS) assay for detecting HIV-1 drug resistance mutations (DRMs). November […]
